Effects of Chemical Modifications on siRNA Strand Selection in Mammalian Cells.


Journal

Nucleic acid therapeutics
ISSN: 2159-3345
Titre abrégé: Nucleic Acid Ther
Pays: United States
ID NLM: 101562758

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 17 3 2020
medline: 20 8 2021
entrez: 17 3 2020
Statut: ppublish

Résumé

Small interfering RNAs (siRNAs) enable efficient gene silencing through RNA interference (RNAi) mechanisms. The RNAi machinery relies on an RNA-guided nuclease, Argonaute-2 (Ago2), which preferentially selects a single strand from an siRNA duplex. Complementarity between the selected strand and an RNA target strand leads to silencing through cleavage. The U.S. Food and Drug Administration's recent approval of two siRNA drugs has reignited optimism for RNAi therapeutics. Despite this recent success in the field, off-target effects are still a major concern; however, chemical modifications have shown promise in mitigating some off-target gene silencing. To evaluate the impact of novel chemical modifications on strand selection, we developed a quantitative polymerase chain reaction-based assay that is compatible with several pre-existing siRNA libraries and was used to characterize chemically modified siRNAs. siRNAs bearing azobenzene and propargyl modifications at the central region of the passenger strand significantly improved strand selection. On the other hand, folic acid-modified siRNAs improved strand selection best when placed at the 3' terminus. This study highlights the development and utility of a convenient method to evaluate the impact that novel chemical modifications have on strand-specific gene silencing of siRNAs.

Identifiants

pubmed: 32175808
doi: 10.1089/nat.2020.0848
doi:

Substances chimiques

AGO2 protein, human 0
Argonaute Proteins 0
Azo Compounds 0
RNA, Double-Stranded 0
RNA, Small Interfering 0
Folic Acid 935E97BOY8
azobenzene F0U1H6UG5C

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

229-236

Auteurs

Andrew J Varley (AJ)

Faculty of Science, University of Ontario Institute of Technology, Oshawa, Canada.

Matthew L Hammill (ML)

Faculty of Science, University of Ontario Institute of Technology, Oshawa, Canada.

Lidya Salim (L)

Faculty of Science, University of Ontario Institute of Technology, Oshawa, Canada.

Jean-Paul Desaulniers (JP)

Faculty of Science, University of Ontario Institute of Technology, Oshawa, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH